Copyright © Inderes 2011 - present. All rights reserved.

I-tech

49,70 SEK

-3,68 %

Mindre end 1K følgere

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-3,68 %
+7,58 %
-4,79 %
-4,79 %
-47,13 %
-41,39 %
-28,39 %
-34,00 %
+101,50 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Læs mere
Markedsværdi
596,29 mio. SEK
Aktieomsætning
107,17 t SEK
Omsætning
168,12 mio.
EBIT %
24,41 %
P/E
17,75
Udbytteafkast, %
2,52 %
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
7.5
2026

Delårsrapport Q1'26

21.8
2026

Delårsrapport Q2'26

16.10
2026

Delårsrapport Q3'26

ViserAlle indholdstyper
Eksterne analyser

I-tech: Another growth breather in Q1e - ABG

* Q1e sales 42m (57m), adj. EBIT SEK 9.8m (18m) * Updated FX forecasts, we raise '26e-'28e sales by 4-5% * Trading at '26e-'28e EV/EBIT of 8x-3x Q1 expectations We estimate sales of SEK 42m (57m), -27% y-o-y (-15%% org., -12% FX). I-Tech is facing tough...

I-tech

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Eksterne analyser

I-tech: A pause in pace, not the story - ABG

* Q4: -23% organic growth (vs. ABGSCe -12%) * Financially constrained customer weighed on ’25 org. growth * Long-term potential intact, expect continued CMP growth in '26e 2025, a mixed financial year Q4 organic growth came in below our estimate at -...

I-tech
Eksterne analyser

I-tech: Customer pullback weighing on growth - ABG

Sales -13% vs. ABGSCe, EBIT SEK 7.6m vs. ABGSCe 9.4m * Three coating products launched in Korea in Q4 * Sizeable customer with financial constraints impacting volumes Q4 results I-Tech reported sales of SEK 39m, falling 13% short of our estimate (-33...

I-tech
Eksterne analyser

I-tech: No easy lap into Q4e - ABG

* Q4e sales SEK 45m (58m), adj. EBIT SEK 10m (19m) * We cut '26e-'27e sales and EBIT by 10% and 22-19%, respectively * Lowered growth assumptions for CMP Tough comps in Q4e We estimate Q4 sales of SEK 45m, -23% y-o-y (-12% organic, -11% FX). I-Tech is...

I-tech
Eksterne analyser

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

I-tech
Eksterne analyser

I-tech: Customer slowdown tempers growth - ABG

* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than ...

I-tech
Eksterne analyser

I-tech: Q3 impacted by weaker market conditions - ABG

Sales -18% vs. ABGSCe, EBIT SEK 11m vs. ABGSCe 16m* Newbuild market down 50% y-o-y, affecting growth* Sizeable customer has reduced planned volumes for '25Q3 resultsQ3 sales came in lower than expected at SEK 41m (-18% vs. ABGSCe 50m). The company writes...

I-tech
Eksterne analyser

I-tech: Sales recovery expected in Q3 - ABG

* Report out on 17 October* Q3e sales of SEK 50m, +23% y-o-y, EBIT SEK 16m (9m)* Q3 rebound expected after Q2 dip Q3 expectations We estimate Q3 sales of SEK 50m, +23% y-o-y (+35% organic, -12% FX). We expect Q3 to demonstrate that Q2 was a temporary...

I-tech
Eksterne analyser

I-tech: A pause, not a stop - ABG

* Weaker Q2 due to natural quarterly variations* Cut '25e-'27e EBIT by 12-13%* Demand intact, rebound expected in Q3Growth halted, but we expect a rebound in Q3I-Tech reported weaker Q2 sales of SEK 32m (-39% vs. ABGSCe, -26% y-o-y) and EBIT of SEK 5m...

I-tech
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.